Germany – Pharmaceutical products

Original title (German): Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Bosutinib, ATC L01EA04

Health · Germany government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

October 05, 2026
Response Due
Active
Status

About this record

The issuing agency did not publish a description for this notice. The full record as GlobalGov received it is below.

This Germany Pharmaceuticals opportunity is one most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyHealth
CountryGermany
CategoryPharmaceuticals
PublishedOctober 17, 2024
Procurement stageActive solicitation
Response dueOctober 05, 2026
StatusOpen — accepting responses
Original languageGerman — members read it in their own language
Official sourceView original notice
Last verifiedSeptember 18, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Related Opportunities in Germany

Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient rilpivirine, ATC J05AG05, for the period 01.07.2025 - 30.06.2027
Germany – Pharmaceutical products
Germany – Pharmaceutical products
Germany – Pharmaceutical products
Germany – Pharmaceutical products
Germany – Pharmaceutical products
Germany – Pharmaceutical products
Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient budesonide, ATC A07EA06, for the period 01.03.2026 - 29.02.2028 (plus extension option of 1 x 12 months)

See every Germany Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Pharmaceuticals intelligence report in your inbox

A personalized report on Germany Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.